Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis (Q34316776)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Jeroen P Jansen

4

object named as

Jeroen P Jansen

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Shannon Cope

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jie Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

James Williams

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

25 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

BMC Pulmonary Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Network meta-analysis of individual and aggregate level data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Patient adherence in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

6 July 2018

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-12-29

21 January 2018

Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3512498

28 October 2018

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

St. George's Respiratory Questionnaire: MCID

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tiotropium improves FEV1 in patients with COPD irrespective of smoking status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/22732017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2466-12-29

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34316776&oldid=2196497927"